Literature DB >> 28448645

Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.

Samantha Tam1, Rakhna Araslanova1, Tsu-Hui Hubert Low2, Andrew Warner3, John Yoo4, Kevin Fung4, S Danielle MacNeil4, David A Palma5, Anthony C Nichols6.   

Abstract

Importance: Locoregional recurrence of oral cavity squamous cell carcinoma (OCSCC) continues to be a life-threatening and difficult clinical situation. Salvage surgery can result in significant morbidities, and survival following recurrence is poor. Objective: To outline prognostic factors influencing overall survival (OS) following salvage surgery for OCSCC to guide management of treatment for patients with locoregionally recurrent disease. Design, Setting, and Participants: The medical records of 293 patients presenting to the London Health Sciences Center with locoregionally recurrent OCSCC between October 5, 1999, and May 2, 2011, were retrospectively reviewed. The primary outcome was OS from salvage treatment to last follow-up or death. Univariate analyses were carried out using the Cox proportional hazards regression model. A recursive partitioning analysis was used to create risk groups based on prognosis. Analysis was conducted from December 8, 2015, to February 26, 2016.
Results: Of the 293 patients evaluated, 59 (20%) had recurrence identified after their initial OCSCC treatment; 39 (66%) were men, and the mean (SD) age at diagnosis was 62.2 (11.8) years. Thirty-nine (66%) of these patients underwent salvage surgery for locoregional recurrence with curative intent. Five-year OS from the time of salvage surgery was 43%. Recursive partitioning analysis identified 3 risk groups: (1) high risk (patients who received adjuvant chemoradiotherapy or radiotherapy after initial surgery) with 5-year OS rate of 10% (hazard ratio [HR], 9.41; 95% CI, 2.68-33.04), (2) intermediate risk (previous surgery alone, age ≥62 years) with a 5-year OS rate of 39% (HR, 2.95; 95% CI, 0.86-10.09), and (3) low risk (previous surgery alone, age <62 years) with 5-year OS rate of 74%. Conclusions and Relevance: This recursive partitioning analysis identified 3 prognostic groups in patients undergoing salvage surgery for recurrent OCSCC. The marked differences in survival between these groups should be taken into consideration when counselling and managing treatment for patients with locoregionally recurrent disease.

Entities:  

Mesh:

Year:  2017        PMID: 28448645      PMCID: PMC5824200          DOI: 10.1001/jamaoto.2017.0001

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  15 in total

1.  Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.

Authors:  Caroline H Shiboski; Brian L Schmidt; Richard C K Jordan
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

2.  Surgical salvage for local and regional recurrence in oral cancer.

Authors:  Robert A Ord; Antonia Kolokythas; Mark A Reynolds
Journal:  J Oral Maxillofac Surg       Date:  2006-09       Impact factor: 1.895

3.  Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.

Authors:  Mitsuo Goto; Nobuhiro Hanai; Taijiro Ozawa; Hitoshi Hirakawa; Hidenori Suzuki; Ikuo Hyodo; Takeshi Kodaira; Tetsuya Ogawa; Yasushi Fujimoto; Akihiro Terada; Hisakazu Kato; Yasuhisa Hasegawa
Journal:  Asia Pac J Clin Oncol       Date:  2013-08-02       Impact factor: 2.601

4.  Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity.

Authors:  Bon Seok Koo; Young Chang Lim; Jin Seok Lee; Eun Chang Choi
Journal:  Oral Oncol       Date:  2006-02-07       Impact factor: 5.337

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

6.  Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?

Authors:  Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; I-How Chen; Shiang-Fu Huang; Ann-Joy Cheng; Tzu-Chen Yen
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

7.  Management of recurrent head and neck cancer: variables related to salvage surgery.

Authors:  Laura Gañán; Montserrat López; Jacinto García; Eduard Esteller; Miquel Quer; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-17       Impact factor: 2.503

8.  Squamous cell carcinoma of the oral tongue in young patients: a matched-pair analysis.

Authors:  Ching-Chih Lee; Hsu-Chueh Ho; Huang-Li Chen; Shih-Hsuan Hsiao; Juen-Haur Hwang; Shih-Kai Hung
Journal:  Acta Otolaryngol       Date:  2007-11       Impact factor: 1.494

9.  Salvage surgery as the primary treatment for recurrent oral squamous cell carcinoma.

Authors:  Yen-Chun Lin; Jenn-Ren Hsiao; Sen-Tien Tsai
Journal:  Oral Oncol       Date:  2004-02       Impact factor: 5.337

10.  Salvage treatment for recurrent oral squamous cell carcinoma.

Authors:  Guo-Wen Sun; En-Yi Tang; Xu-Dong Yang; Qin-Gang Hu
Journal:  J Craniofac Surg       Date:  2009-07       Impact factor: 1.046

View more
  8 in total

1.  The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis.

Authors:  Jorge J De La Chapa; Prajjal K Singha; Kristen K Self; McKay L Sallaway; Stanton F McHardy; Matthew J Hart; Howard Stan McGuff; Matthew C Valdez; Francisco Ruiz; Srikanth R Polusani; Cara B Gonzales
Journal:  J Oral Pathol Med       Date:  2019-04-04       Impact factor: 4.253

2.  Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.

Authors:  Evangelia Katsoulakis; Jonathan E Leeman; Benjamin H Lok; Weiji Shi; Zhigang Zhang; Jillian C Tsai; Sean M McBride; Eric J Sherman; Marc Cohen; Richard Wong; Ian Ganly; Nancy Y Lee; Nadeem Riaz
Journal:  Laryngoscope       Date:  2018-04-10       Impact factor: 3.325

3.  Choice of Regional Flaps for Oral Cancer Defects: Relevance in Current Era.

Authors:  G Lakshminarayana; Shruti Venkitachalam; C S Mani
Journal:  J Maxillofac Oral Surg       Date:  2019-11-22

4.  Salvage surgery with second free flap reconstruction for recurrent oral squamous cell carcinoma.

Authors:  Tae-Young Jung; Ki-Woong Sung; Sang-Yoon Park; Soung-Min Kim; Jong-Ho Lee
Journal:  Heliyon       Date:  2020-06-11

Review 5.  Head and neck cancer patients declining curative treatment: a case series and literature review.

Authors:  Axel Sahovaler; Tommaso Gualtieri; David Palma; Kevin Fung; S Danielle MacNeil; John Yoo; Anthony Nichols
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

Review 6.  Salvage Surgery in Recurrent Oral Squamous Cell Carcinoma.

Authors:  K S Rathan Shetty; Vinayak Kurle; P Greeshma; Veena B Ganga; Samskruthi P Murthy; Siddappa K Thammaiah; P Krishna Prasad; Purushottham Chavan; Rajshekar Halkud; R Krishnappa
Journal:  Front Oral Health       Date:  2022-01-28

7.  Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors:  Yue He; Zhonglong Liu; Surui Sheng; Weijin Gao; Xiao Tang; Xiaoguang Li; Chunyue Ma
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

8.  MMP2 as an independent prognostic stratifier in oral cavity cancers.

Authors:  Caroline Hoffmann; Sophie Vacher; Philémon Sirven; Charlotte Lecerf; Lucile Massenet; Aurélie Moreira; Aurore Surun; Anne Schnitzler; Jerzy Klijanienko; Odette Mariani; Emmanuelle Jeannot; Nathalie Badois; Maria Lesnik; Olivier Choussy; Christophe Le Tourneau; Maude Guillot-Delost; Maud Kamal; Ivan Bieche; Vassili Soumelis
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.